天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

methyl 5-chloroH-imidazo[1,2-a]pyridine-8-carboxylate

methyl 5-chloroH-imidazo[1,2-a]pyridine-8-carboxylate Struktur
1402911-36-7
CAS-Nr.
1402911-36-7
Englisch Name:
methyl 5-chloroH-imidazo[1,2-a]pyridine-8-carboxylate
Synonyma:
methyl 5-chloroimidazo[1,2-a]pyridine-8-carboxylate;methyl 5-chloroH-imidazo[1,2-a]pyridine-8-carboxylate;Imidazo[1,2-a]pyridine-8-carboxylic acid, 5-chloro-, methyl ester
CBNumber:
CB73091220
Summenformel:
C9H7ClN2O2
Molgewicht:
210.62
MOL-Datei:
1402911-36-7.mol

methyl 5-chloroH-imidazo[1,2-a]pyridine-8-carboxylate Eigenschaften

Dichte
1.42±0.1 g/cm3(Predicted)
pka
2.40±0.50(Predicted)

Sicherheit

methyl 5-chloroH-imidazo[1,2-a]pyridine-8-carboxylate Chemische Eigenschaften,Einsatz,Produktion Methoden

methyl 5-chloroH-imidazo[1,2-a]pyridine-8-carboxylate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Methyl 2-amino-6-chloronicotinate

Downstream Produkte

methyl 5-chloroH-imidazo[1,2-a]pyridine-8-carboxylate Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 11)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Aladdin Scientific 		+1-+1(833)-552-7181
sales@aladdinsci.com United States 52924 58
Aikon International Limited 025-58859352 18068836627
 sales01@aikonchem.com China 15084 58
Shanghai Naiys Biological Technology Co., Ltd 18321139117
 316441092@qq.con China 3010 58
Hefei Mokai Pharmaceutical Technology Co., Ltd 18130062233
 3362556465@qq.com China 8000 58
Henan Alpha Chemical Co., Ltd. 0371-55013243 15324716602
 2853979810@qq.com China 9990 58
PharmaBlock Sciences (Nanjing), Inc. 4000255188 13327728092
 sales@pharmablock.com China 9698 58
Huanuo Pharmaceutical Technology (Guangxi) Co., Ltd 13005928603
 211017228@qq.com China 6607 58
  • methyl 5-chloroH-imidazo[1,2-a]pyridine-8-carboxylate
  • methyl 5-chloroimidazo[1,2-a]pyridine-8-carboxylate
  • Imidazo[1,2-a]pyridine-8-carboxylic acid, 5-chloro-, methyl ester
  • 1402911-36-7
Copyright 2019 ? ChemicalBook. All rights reserved